{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:18:45Z","timestamp":1787800725289,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rec.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:21:25Z","timestamp":1774628485000},"page":"781-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel insights on ventricular arrhythmias in cardiac amyloidosis: an updated narrative review"],"prefix":"10.1016","volume":"79","author":[{"given":"Caterina","family":"Butturini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Setti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Llamas-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Pe\u00f1a-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Mugnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2026.03.003_bib0345","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, epidemiology, and global burden of cardiomyopathies","volume":"121","author":"McKenna","year":"2017","journal-title":"Circ Res."},{"key":"10.1016\/j.rec.2026.03.003_bib0350","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0355","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-chain) cardiac amyloidosis:a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0360","first-page":"416","article-title":"Arrhythmias in cardiac amyloidosis:challenges in risk stratification and treatment","volume":"36","author":"Cheung","year":"2020","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0365","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/jcm12072581","article-title":"Arrhythmic manifestations of cardiac amyloidosis:challenges in risk stratification and clinical management","volume":"12","author":"Laptseva","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0370","first-page":"1474","article-title":"Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists","volume":"13","author":"D\u2019Errico","year":"2020","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.rec.2026.03.003_bib0375","doi-asserted-by":"crossref","DOI":"10.1177\/1179546820963055","article-title":"Ventricular arrhythmias in cardiac amyloidosis: a review of current literature","volume":"14","author":"Khanna","year":"2020","journal-title":"Clin Med Insights Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0380","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jjcc.2023.02.009","article-title":"Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis","volume":"81","author":"Bukhari","year":"2023","journal-title":"J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0385","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/jcm12051798","article-title":"Infiltration of conduction tissue is a major cause of electrical instability in cardiac amyloidosis","volume":"12","author":"Frustaci","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0390","first-page":"464","article-title":"Risks of ventricular tachyarrhythmia and mortality in patients with amyloidosis \u2013 A long-term cohort study","volume":"38","author":"Chen","year":"2022","journal-title":"Acta Cardiol Sin."},{"key":"10.1016\/j.rec.2026.03.003_bib0395","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM."},{"key":"10.1016\/j.rec.2026.03.003_bib0400","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/jcm13051300","article-title":"Arrhythmias and device therapies in cardiac amyloidosis","volume":"13","author":"Bukhari","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0405","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.rec.2026.03.003_bib0410","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.TP.0000133517.20972.27","article-title":"Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients","volume":"78","author":"H\u00f6rnsten","year":"2004","journal-title":"Transplantation."},{"key":"10.1016\/j.rec.2026.03.003_bib0415","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.rec.2026.03.003_bib0420","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jce.16470","article-title":"Prognosis of patients with wild-type transthyretin cardiac amyloidosis and non-sustained ventricular tachycardia","volume":"36","author":"Sehrawat","year":"2025","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0425","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3390\/jcm10091858","article-title":"Arrhythmic sudden cardiac death and the role of implantable cardioverter-defibrillator in patients with cardiac amyloidosis - A narrative literature review","volume":"10","author":"Li\u017cewska-Springer","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0430","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/bjh.17399","article-title":"Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities?","volume":"193","author":"Zampieri","year":"2021","journal-title":"Br J Haematol."},{"key":"10.1016\/j.rec.2026.03.003_bib0435","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amjcard.2020.12.024","article-title":"Impact of arrhythmias on hospitalizations in patients with cardiac amyloidosis","volume":"143","author":"Thakkar","year":"2021","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0440","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jce.14541","article-title":"Effect of ICD implantation on cardiovascular outcomes in patients with cardiac amyloidosis: A systematic review and meta-anaylsis","volume":"31","author":"Halawa","year":"2020","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0445","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/anec.12967","article-title":"Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis","volume":"27","author":"Ng","year":"2022","journal-title":"Ann Noninvasive Electrocardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0450","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12872-024-04143-z","article-title":"The value of the electrocardiogram in the recognition of cardiac amyloidosis: a systematic meta-analysis","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.rec.2026.03.003_bib0455","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.3390\/jcm13185588","article-title":"Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management - A Narrative Review","volume":"13","author":"Teresi","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0460","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic features and rhythm disorders in cardiac amyloidosis","volume":"34","author":"Martini","year":"2024","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0465","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","article-title":"Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value","volume":"4","author":"Cipriani","year":"2022","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.rec.2026.03.003_bib0470","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jjcc.2015.11.004","article-title":"Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis","volume":"68","author":"Zhao","year":"2016","journal-title":"J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0475","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0480","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ehjci\/jew117","article-title":"ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study","volume":"18","author":"Rodrigues","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2026.03.003_bib0485","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1038\/s41598-019-44245-9","article-title":"Associations of electrocardiographic parameters with left ventricular longitudinal strain and prognosis in cardiac light chain amyloidosis","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.rec.2026.03.003_bib0490","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis:a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.03.003_bib0495","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis:prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin Electrophysiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0500","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.hroo.2024.07.013","article-title":"Monitoring for arrhythmia in transthyretin cardiac amyloidosis with noninvasive ambulatory patch devices","volume":"5","author":"Bruce","year":"2024","journal-title":"Heart Rhythm O2."},{"key":"10.1016\/j.rec.2026.03.003_bib0505","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.03.003_bib0510","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0002-8703(97)70017-6","article-title":"Signal-averaged electrocardiography in patients with AL (primary) amyloidosis","volume":"134","author":"Dubrey","year":"1997","journal-title":"Am Heart J."},{"key":"10.1016\/j.rec.2026.03.003_bib0515","doi-asserted-by":"crossref","first-page":"e012097","DOI":"10.1161\/JAHA.119.012097","article-title":"Noninvasive mapping of the electrophysiological substrate in cardiac amyloidosis and its relationship to structural abnormalities","volume":"8","author":"Orini","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.rec.2026.03.003_bib0520","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","article-title":"LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis","volume":"9","author":"Boynton","year":"2016","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2026.03.003_bib0525","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","article-title":"Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis","volume":"9","author":"Raina","year":"2016","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2026.03.003_bib0530","doi-asserted-by":"crossref","first-page":"oead092","DOI":"10.1093\/ehjopen\/oead092","article-title":"Prognosis prediction in cardiac amyloidosis by cardiac magnetic resonance imaging: a systematic review with meta-analysis","volume":"3","author":"Boretto","year":"2023","journal-title":"Eur Heart J Open."},{"key":"10.1016\/j.rec.2026.03.003_bib0535","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0540","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1002\/ehf2.14975","article-title":"Effect of beta-blockade on mortality in patients with cardiac amyloidosis: A systematic review and meta-analysis","volume":"11","author":"Kwok","year":"2024","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2026.03.003_bib0545","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/13506129.2024.2414295","article-title":"Incidence and predictors of sudden death in patients with cardiac amyloidosis","volume":"31","author":"de Frutos","year":"2024","journal-title":"Amyloid."},{"key":"10.1016\/j.rec.2026.03.003_bib0550","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","article-title":"Conventional heart failure therapy in cardiac ATTR amyloidosis","volume":"44","author":"Ioannou","year":"2023","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.03.003_bib0555","doi-asserted-by":"crossref","first-page":"131813","DOI":"10.1016\/j.ijcard.2024.131813","article-title":"Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis","volume":"402","author":"Kang","year":"2024","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0560","doi-asserted-by":"crossref","first-page":"101604","DOI":"10.1016\/j.jacadv.2025.101604","article-title":"Management of rhythm and conduction disorders in cardiac amyloidosis: a French Nationwide Delphi Study","volume":"4","author":"Guenancia","year":"2025","journal-title":"Jacc Adv."},{"key":"10.1016\/j.rec.2026.03.003_bib0565","doi-asserted-by":"crossref","first-page":"e012788","DOI":"10.1161\/CIRCEP.124.012788","article-title":"Substrate characterization and outcomes of ventricular tachycardia ablation in amyloid cardiomyopathy: A multicenter study","volume":"17","author":"Compagnucci","year":"2024","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0570","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/jcdd10080337","article-title":"Arrhythmias in patients with cardiac amyloidosis: A comprehensive review on clinical management and devices","volume":"10","author":"Briasoulis","year":"2023","journal-title":"J Cardiovasc Dev Dis."},{"key":"10.1016\/j.rec.2026.03.003_bib0575","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.03.003_bib0580","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2026.03.003_bib0585","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.rec.2026.03.003_bib0590","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehaf710","article-title":"Non-amyloid specific treatment for transthyretin cardiac amyloidosis:a clinical consensus statement of the ESC Heart Failure Association","volume":"47","author":"Garcia-Pavia","year":"2026","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.03.003_bib0595","first-page":"408","article-title":"Use of implantable electronic devices in patients with cardiac amyloidosis","volume":"36","author":"John","year":"2020","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0600","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.rec.2026.03.003_bib0605","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.hrcr.2025.02.020","article-title":"A role for defibrillation threshold testing?. A case of ventricular fibrillation refractory to implantable cardioverter-defibrillator shocks in setting of cardiac amyloidosis","volume":"11","author":"Lee","year":"2025","journal-title":"HeartRhythm Case Rep."},{"key":"10.1016\/j.rec.2026.03.003_bib0610","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/jcdd11070222","article-title":"Arrhythmic risk stratification in cardiac amyloidosis: a review of the current literature","volume":"11","author":"Bonvicini","year":"2024","journal-title":"J Cardiovasc Dev Dis."},{"key":"10.1016\/j.rec.2026.03.003_bib0615","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","article-title":"Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring","volume":"104","author":"Goldsmith","year":"2009","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0620","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0625","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00392-022-02035-w","article-title":"Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging","volume":"112","author":"Chamling","year":"2023","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.rec.2026.03.003_bib0630","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/ehf2.14815","article-title":"Impact of tafamidis on myocardial function and CMR tissue characteristics in transthyretin amyloid cardiomyopathy","volume":"11","author":"Dobner","year":"2024","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2026.03.003_bib0635","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2026.03.003_bib0640","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0645","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.02.004","article-title":"Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis","volume":"76","author":"Le Bras","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.rec.2026.03.003_bib0650","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2011-10-388462","article-title":"Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival","volume":"119","author":"Venner","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.rec.2026.03.003_bib0655","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2026.03.003_bib0660","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2023.11.016","article-title":"Effect of eplontersen on cardiac structure and function in patients with hereditary transthyretin amyloidosis","volume":"30","author":"Masri","year":"2024","journal-title":"J Card Fail."},{"key":"10.1016\/j.rec.2026.03.003_bib0665","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","volume":"389","author":"Garcia-Pavia","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.03.003_bib0670","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.2020009039","article-title":"Phase 1a\/b study of monoclonal antibody CAEL-101(11-1F4) in patients with AL amyloidosis","volume":"138","author":"Edwards","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.rec.2026.03.003_bib0675","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res."},{"key":"10.1016\/j.rec.2026.03.003_bib0680","doi-asserted-by":"crossref","first-page":"1400101","DOI":"10.3389\/fimmu.2024.1400101","article-title":"Cardiovascular adverse events associated with targeted therapies for multiple myeloma: a pharmacovigilance study","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585726000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585726000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:41:47Z","timestamp":1787798507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585726000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1885585726000587"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2026.03.003","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights on ventricular arrhythmias in cardiac amyloidosis: an updated narrative review","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2026.03.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}